🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single centre, proof-of-concept phase I trial of atezolizumab in ...
Status
Active Not Recruiting
Location
Royal Marsden Hospital NHS Foundation Trust
Start Date
2018-08-13
Trial ID
NCT03673787
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
This study will randomized hematology oncology patients with active diarrhe...
Status
Completed
Location
Froedtert and the Medical College of Wisconsin
Start Date
2018-06-01
Trial ID
NCT03030248
Treatments Being Tested
Crohn's disease (CD) is a chronic inflammatory bowel disease. CD pathogenes...
Status
Recruiting
Location
Gastroenterology Department of Saint Antoine Hospital
Start Date
2021-09-22
Trial ID
NCT04997733
Treatments Being Tested
France is among the countries with a high incidence of colorectal cancer. T...
Status
Completed
Location
Hopsices Civils de Lyon
Start Date
2014-06
Trial ID
NCT02558881
Treatments Being Tested
The purpose of this research project is to ascertain the effectiveness of p...
Status
Completed
Location
Parkland Memorial Hospital
Start Date
2008-09
Trial ID
NCT00904228
The aim of this study was to determine the subcutaneous connective tissue r...
Status
Completed
Location
Eskişehir Osmangazi University
Start Date
2019-04-01
Trial ID
NCT04652323
Treatments Being Tested
The purpose of this study is to compare the colon cleansing quality of lina...
Status
Completed
Location
Ningxia Hui Autonomous Region People's Hospital
Start Date
2022-08-01
Trial ID
NCT05379491
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested